Hepoxilin A3 inhibits agonist-evoked rise in free intracellular calcium in human neutrophils.
Pace-Asciak
C R
CR
Research Institute, Hospital for Sick Children, Toronto, Canada.
Reynaud
D
D
Laneuville
O
O
Grinstein
S
S
Nigam
S
S
D015126:8,11,14-Eicosatrienoic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D002118:Calcium / Q000097:blood* / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D007975:Leukotriene B4 / Q000494:pharmacology; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D010972:Platelet Activating Factor / Q000494:pharmacology
D010972:Platelet Activating Factor; D007975:Leukotriene B4; D009240:N-Formylmethionine Leucyl-Phenylalanine; C038243:8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid; D015126:8,11,14-Eicosatrienoic Acid; D002118:Calcium